Introduction
The genus Taxus L. (Taxaceae), known as "yew", is widely distributed in the northern hemisphere, especially in Europe, North America, Eastern Asia and Asia Minor. There are eight Taxus species and two hybrids throughout the world, and T. baccata L. (European yew) is the single representative of the genus in Turkey (Davis and Cullen, 1965; Van Rozendall et al., 1999) . The discovery of paclitaxel (Taxol TM ) from the bark of the Pacifi c yew (Taxus brevifolia Nutt.) and its introduction into cancer chemotherapy have attracted many scientists to investigate the chemical constituents of other Taxus species growing worldwide. Paclitaxel is the most important agent in human cancer chemotherapy and used for the treatment of several forms of breast, liver, lung, blood, and ovary cancers (Rowinsky, 1997) . Up till now, isolation of a great number of taxoids as well as lignans, fl avonoids, steroids, and sugar derivatives has been reported from different parts of various Taxus species (Baloglu and Kingston, 1999; Parmar et al., 1999) .
Since all plant parts of yew, except arillus, contain toxic taxine alkaloids, the plant has been rarely documented as folk medicine. It was reported to be used as antimalarial and antirheumatic in historical documents (Bryan-Brown, 1932; Appendino, 1993) . In Ayurvedic medicine, known indigenously as Talispatra, it is recommended to be used as emmenagogue, sedative, antispasmodic, and aphrodisiac (Bryan-Brown, 1932; Shanker et al., 2002) , as well as to treat asthma (Singh, 1995) . Besides, a literature survey revealed that it was also listed in Avicenna's cardiac drugs, namely Zarnab (Tekol, 1989) . In Turkish folk medicine, it is known to be used as sedative and stomachic (Baytop, 1999) .
A great number of pharmacological effects have been ascribed to lignans such as antibacterial, antifungal, antiviral, antioxidant, anticancer, and anti-infl ammatory (Rios et al., 2002 Phytochemical investigations of Taxus baccata L. by successive chromatographic methods resulted in the isolation of the lignans lariciresinol (1), taxiresinol (2), 3'-demethylisolariciresinol-9'-hydroxyisopropylether (3), isolariciresinol (4), and 3-demethylisolariciresinol (5) as well as taxoids. Compounds 1 -5 were evaluated for their acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and lipoxygenase (LOX) inhibitory activities, which play a role in the pathogenesis of Alzheimer's disease (AD), by in vitro spectrophotometric methods, while they were also screened for their antioxidant capacity in 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, ferrous ion-chelating effect, and ferric-reducing antioxidant power (FRAP) at 125, 250, 500, and 1000 μg ml -1
. All compounds exhibited a moderate inhibition against both BChE and LOX, whereas they were inactive towards AChE. The compounds displayed a great scavenging activity against DPPH especially at 500 and 1000 μg ml -1
. Besides, they were found to exert noteworthy reducing antioxidant power on ferric ions. In particular, the FRAP of compounds 2 (3.552 ± 0.02), 4 (3.021 ± 0.71), and 5 (3.533 ± 0.01) were as high as that of the reference chlorogenic acid (3.618 ± 0.01) at 1000 μg ml -1 . None of the compounds exhibited chelating ability against ferrous ions.
Turkey by successive chromatographic methods resulted in the isolation of fi ve lignans, namely lariciresinol (1), taxiresinol (2), 3'-demethylisolariciresinol-9'-hydroxyisopropylether (3), isolariciresinol (4), and 3-demethylisolariciresinol (5) (Erdemoglu et al., , 2004a . In our previous studies, in vivo anti-infl ammatory and antinociceptive activities and in vivo antiulcerogenic potency of the lignans 1 -5 isolated from T. baccata were investigated (Kupeli et al., 2003; Gurbuz et al., 2004) . All compounds were shown to possess signifi cant antinociceptive activity against pbenzoquinone-induced abdominal stretching and signifi cantly inhibited carrageenan-induced hind paw edema in mice (Kupeli et al., 2003) . Besides, these compounds were shown to possess significant anti-ulcerogenic activity and among them, taxiresinol was found to be the most prominent (Gurbuz et al., 2004) . In our other previous study on bioactivity of lignans from T. baccata, three lignan derivatives, 2, 3 and 5, were evaluated for their cytotoxicity against the Oncology Cell Line Panel (breast, colon, ovary, prostate, lung and a normal adult bovine aortic endothelial cell line) as well as for their antimicrobial activity. None of the investigated compounds demonstrated much cytotoxic potency as compared to the reference drug etoposide. With the exception of compound 3, the other two lignans 2 and 5 showed a remarkable antifungal activity, whereas none of the compounds displayed antibacterial activity (Erdemoglu et al., 2004b ). Alzheimer's disease (AD) is a progressive, neurodegenerative disorder resulting in impaired memory and cognitive function. Since the populations of many developed countries are aging, AD represents an increasingly important social, health, and economic problem worldwide. According to the cholinergic hypothesis, memory impairments in patients suffering from AD is a result from a defi cit of cholinergic function in brain . Acetylcholinesterase (AChE) is the most important enzyme regulating the level of acetylcholine (ACh), whereas butyrylcholinesterase (BChE) also plays a role in the pathology of AD. It has been accepted that AChE and BChE inhibition is the most used treatment for the symptoms of AD and related dementias Scarpini et al., 2003) . In recent literatures, new therapies targeted at the underlying pathology of AD give the promise of diseasemodifying approaches. The use of anti-infl ammatory agents has also been suggested to delay the progression of AD (Scarpini et al., 2003; Reale et al., 2004) .
Lipoxygenases (LOXs) constitute a family of non-haem iron-containing dioxygenases that are widely distributed in animals and plants. In mammalian cells, these are key enzymes in the biosynthesis of a variety of bioregulatory compounds such as hydroxyeicosatetraenoic acids (HETEs), leukotrienes, lipoxins and hepoxylines (Lands, 1985) . It has been reported that these LOX products play a role in a number of disorders such as bronchial asthma, infl ammation, and tumour angiogenesis. Thus, LOXs are potential targets for the rational drug design and discovery of mechanismbased inhibitors for the treatment of bronchial asthma, infl ammation, cancer and autoimmune diseases (Steinhilber, 1999; Nie and Honn, 2002) .
In continuation of our studies on screening of Turkish medicinal plants and their secondary metabolites for enzyme inhibitory activity to be used as potential leading compounds in the treatment of AD since the year 2000, this time, we have screened the lignans obtained from T. baccata. These lignans ( Fig. 1) were evaluated for their AChE, BChE, and LOX inhibitory activities by in vitro spectrophotometric methods using an ELISA microplate reader. In addition, the compounds were screened for their antioxidant capacity in 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, ferrous ion-chelating effect, and ferric-reducing antioxidant power (FRAP) at 125, 250, 500, and 1000 μg ml -1 .
Material and Methods

General
Column chromatography (CC) was performed using Silica gel (Kieselgel 60, 0.063 -0.200 mm, Art. 7734, Merck), and Kieselgel 60 F 254 (0.5 mm thickness, Art. 5554, Merck) was used for preparative thin layer chromatography (TLC). Analytical TLC was performed on precoated plates (Kieselgel 60 F 254 , Art. 5554, Merck), visualized under UV light at 254 nm, and then sprayed with anisaldehyde reagent [76% methanol (Merck), 19% ortho-phosphoric acid (Riedel-De Haën, Buchs, Switzerland), 5% p-anisaldehyde (Merck)] and heated.
Plant material
Taxus baccata L. (Taxaceae) was collected from the vicinity of Çamlıhemşin-Rize (Turkey) at an altitude of 1400 m, in June 2000. A voucher specimen (GUE 1560) was deposited in the Herbarium of Faculty of Pharmacy, Gazi University, Ankara, Turkey.
Extraction and isolation
The heartwood of the plant was dried in the shade and powdered to a fi ne grade. The material (3078 g) was extracted with 95% ethanol (EtOH) at room temperature. The EtOH extract was evaporated under reduced pressure to give a reddish residue. The residue (308.91 g) was dissolved in distilled H 2 O and extracted with chloroform (CHCl 3 ). The CHCl 3 phase was concentrated under reduced pressure to give a concentrate (63.54 g). A portion (49 g) of the CHCl 3 extract was subjected to silica gel column chromatography (CC). The column was eluted with solvents of increasing polarity using hexane, acetone, CHCl 3 and methanol (CH 3 OH), which led to the collection of seven main fractions (I-VII). Each fraction was further purifi ed by CC, followed by preparative thin layer chromatography (PTLC) or recrystallization.
Elution with CHCl 3 /CH 3 OH (80:20) afforded fraction Fr. VII (5.65 g), which was again subjected to silica gel CC employing CHCl 3 /CH 3 OH (100:0 → 92:8, v/v) as the eluting solvent mixture to afford sixty-four subfractions. Subfractions 11 -13 were subjected to PTLC with CHCl 3 / CH 3 OH (90:10, v/v) to yield 1 (45.7 mg, 0.0028%) and 3 (20.2 mg). Compound 3 (42.6 mg) was also obtained from subfractions 14 -22 through recrystallization using CHCl 3 , and the total yield of 3 was 62.8 mg (0.0039%). Subfractions 47 -52 were further separated by PTLC using CHCl 3 /CH 3 OH (80:20, v/v) to afford 2 (84.6 mg, 0.0052%). Subfractions 28 -33 were crystallized from CHCl 3 to give 4 (41.3 mg, 0.0026%). Subfractions 58 -64 were subjected to CC on silica gel and eluted with CHCl 3 /CH 3 OH (100:0 → 80:20, v/v) to give fractions 4 -14, which were purifi ed by PTLC developed with CHCl 3 /CH 3 OH (80:20, v/v) to afford 5 (71.4 mg, 0.0044%).
LOX inhibition
LOX-inhibiting activity was measured by modifying the spectrophotometric method developed by Tappel (1962) . LOX (EC 1.13.11.12, type I-B), baicalein, and linoleic acid were purchased from Sigma (St. Louis, MO, USA). Baicalein was used as the reference drug. All other chemicals were of analytical grade. The reaction mixture contained 165 μl (100 mM) sodium phosphate buffer (pH 8.0), 5.0 μl of test compound solution and 20 μl of enzyme solution, and was incubated for 10 min at 25 ºC. The reaction was then initiated by the addition of 10 μl of linoleic acid (substrate). Due to the formation of (9Z,11E)-(13S)-13-hydroperoxyoctadeca-9,11-dienoate, the change of absorbance at 234 nm was followed for 6 min. Test compounds and the control were dissolved in CH 3 OH. All reactions were performed in 96-well microplates using an ELISA microplate reader (SpectraMax Plus 384 , Molecular Devices, Sunnyvale, CA, USA). The percentage (%) inhibition was calculated as (E -S)/E · 100, where E is the activity of the enzyme without test compound, and S is the activity of enzyme with test compound. The IC 50 values were then calculated using the EZ-Fit enzyme kinetics software program (Perrella Scientifi c Inc., Amshert, USA).
AChE and BChE inhibition
Electric eel AChE (EC 3.1.1.7, type VI-S), horseserum BChE (EC 3.1.1.8), acetylthiocholine iodide, butyrylthiocholine chloride, 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), and eserine (the reference) were purchased from Sigma. Buffers and other chemicals were of extrapure analytical grade. Galanthamine (Reminyl ® , Johnson & Johnson, Langhorne, PA, USA) was used as another reference drug. AChE-and BChE-inhibiting activities were measured by slightly modifying the spectrophotometric method developed by Ellman et al. (1961) . The reaction was carried out in 100 mM sodium phosphate buffer, pH 8.0, at 25 °C. In a typical assay, 140 μl buffer, 20 μl enzyme preparation, and 20 μl test compound solution were mixed and incubated for 30 min. 10 μl of DTNB were then added, and the reaction was started by adding 10 μl of acetylthiocholine as substrate for AChE. Butyrylthiocholine chloride was used as substrate for BChE, while all other reagents and conditions were the same as previously described (Orhan et al., 2008) . The hydrolysis of acetylthiocholine or butyrylthiocholine was monitored at 412 nm through the formation of the yellow 5-thio-2-nitrobenzoate anion because of the reaction of DTNB with thiocholine, released by the enzymatic hydrolysis of acetylthiocholine or butyrylthiocholine. Test compounds and the control were dissolved in CH 3 OH, which was used as negative control. The concentrations of the test compounds that inhibited the hydrolysis of the substrates (acetylthiocholine and butyrylcholine) by 50% (IC 50 values) were determined by monitoring the effect of increasing concentrations of these compounds in the assays on the inhibition values. The IC 50 values were then calculated using the EZ-Fit enzyme kinetics software program (Perella Scientifi c Inc.).
DPPH radical scavenging activity
The DPPH radical scavenging activity was determined by Blois's method (1958) . The samples and references dissolved in ethanol (75%) were mixed with DPPH solution (1.5 · 10 -4 M). Remaining DPPH was measured at 520 nm using a Unico 4802 UV-visible double beam spectrophotometer (Dayton, NJ, USA). Gallic acid was employed as the reference. Inhibition of DPPH in percent (I%) was calculated as follows: I% = [(A blank -A sample )/ A blank ] · 100, where A blank is the absorbance of the control reaction (containing all reagents except the test sample), and A sample is the absorbance of the compounds/reference.
Ferrous ion-chelating effect
The ferrous ion-chelating effect by the Fe 2+ -ferrozine test system was estimated by the method of Chua et al. (2008) . Briefl y, the samples dissolved in methanol were incubated with 2 mM FeCl 2 solution. The reaction was initiated by the addition of ferrozine solution, and the mixture was left standing at ambient temperature for 10 min. The absorbance of the reaction mixture was measured at 562 nm. The ratio of inhibition (I%) of Fe 2+ -ferrozine complex formation was calculated as follows: I% = [(absorbance of control -absorbance of test sample)/absorbance of control] · 100. The control contained only FeCl 2 and ferrozine.
Ferric-reducing antioxidant power (FRAP) assay
The ferric-reducing power was tested using the assay of Oyaizu (1986) . According to the method, the compounds as well as chlorogenic acid as reference for comparative purposes were added to phosphate buffer (pH 6.6) and potassium ferricyanide. Later, the mixture was incubated at 50 ºC for 20 min, and then trichloroacetic acid was added. After the mixture was shaken vigorously, this solution was mixed with distilled water and FeCl 3 (0.1%, w/v). After 30 min of incubation, absorbance was read at 700 nm using a Unico 4802 UVvisible double beam spectrophotometer. Analyses were achieved in duplicate. Increased absorbance of the reaction meant increased reducing power.
Statistical analysis
Results were expressed as means ± S.E.M. (standard error mean) of fi ve replicates for enzyme inhibition tests and triplicates for antioxidant assays.
Results and Discussion
Five lignans, namely lariciresinol (1), taxiresinol (2), 3'-demethylisolariciresinol-9'-hydroxyisopropylether (3), isolariciresinol (4), and 3-demethylisolariciresinol (5) (Fig. 1) , were isolated from the heartwood of T. baccata, and their structures were identifi ed using extensive spectroscopic techniques (Erdemoglu et al., , 2004a . The isolated lignans were tested for AChE, BChE, and LOX inhibitory activities as well as their antioxidant potentials since AD is associated with oxidative stress (Table I) .
As shown in Table I , compounds 1 -3, and 5 exerted inhibitory activity against BChE to some extents. Compound 4 was completely inactive in this assay. They showed moderate inhibitory activity against LOX, and their IC 50 values varied between 161.0 and 300.0 μM. However, since they displayed AChE inhibitory activity below 50%, their IC 50 values were not worth to calculate for this assay. Among the tested compounds, 3'-demethylisolariciresinol-9'-hydroxyisopropylether (3) possessed the highest inhibitory activity against both BChE and LOX with IC 50 values of (86.0 ± 0.2) and (161.0 ± 3.6) μM, respectively.
The antioxidant capacity of the compounds was tested in three assays, DPPH radical scavenging, ferrous ion-chelating effect, and ferric-reducing antioxidant power (FRAP) tests at 125, 250, 500, and 1000 μg ml -1 . As shown in Table II , the compounds had a remarkable scavenging effect against DPPH radicals, compounds 5 and 2 were the best scavengers at 1000 μg ml -1 as compared to gallic acid, a natural antioxidant used as reference. However, none of the compounds had ability to chelate ferric ions. In the FRAP test, the compounds exhibited quite noteworthy activity (Table III) . Particularly, at a concentration of 1000 μg ml -1 , compounds 2, 4, and 5 had an effect comparable to that of the reference, chlorogenic acid.
Lignans are one of the important classes of secondary metabolites. They have been so far reported with many desired biological activities (Rios et al., 2002) ; however, in our literature survey, there was a limited number of reports on inhibitory activities of lignan derivatives against AChE, BChE, or LOX enzymes. For instance, fourteen lignans isolated from Schizandra chinensis were evaluated for their AChE inhibitory effects and, among them, lignans containing both aromatic methylene dioxy and hydroxy groups on their cyclooctadiene ring, such as gomisin C, gomisin G, gomisin D, schisandrol B, and gomisin A, were found to inhibit AChE totally in a dose-dependent manner, with IC 50 values of (6.71 ± 0.53), (6.55 ± 0.31), (7.84 ± 0.62), (12.57 ± 1.07), and (13.28 ± 1.68) μM, respectively (Tran et al., 2007) . In a previous study, arylnaphthalene-type lignans (diphyllin acetylapioside, especially) acting as LOX inhibitors were stated to be responsible for the topical anti-infl ammatory activity of Haplophyllum hispanicum . On the other hand, two new lignans named negundins A and B along with (+)-diasyringaresinol and (+)-lyoniresinol isolated from Vitex negundo were tested for their LOX and BChE inhibitory effects, and negundin B was found to have potent inhibitory activity against LOX (Azhar-ul-Haq et al., 2004) . Several other lignan derivatives, namely (+)-3,4,3',4'-tetrahydroxy-9,7'α-epoxylignano-7α,9'-lactone, (+)-3,3'-bisdeme thyl tanegool, (-) -pi noresinol, and (-)-3,3'-bisdemethylpinoresinol, obtained from the fruits of noni (Morinda citrifolia) collected in Tahiti were screened against LOX, and all of them showed LOX inhibition to some extent (Deng et al., 2007) . Nevertheless, we have not encountered any report on inhibitory activities of the lignans tested herein, lariciresinol (1), taxiresinol (2), 3'-demethylisolariciresinol-9'-hydroxyisopropylether (3), isolariciresinol (4), and 3-demethylisolariciresinol (5), on AChE, BChE, or LOX enzymes.
Up to date, a number of studies have been reported on antioxidant activities of lignan derivatives. In a study by Baderschneider and Winterhalter (2001) , the antioxidant activity of six novel lignans, i.e., lariciresinol 4-O-glucoside, three isolariciresinol derivatives, and two secoisolariciresinols isolated from wine, were tested in the Trolox-equivalent antioxidant capacity (TEAC) test, and they were found to have a good activity (1.9 -2.5 mmol TEAC mmol -1 ). Five pure woodderived lignans were assayed in the antioxidant potency and the superoxide and peroxyl radical scavenging capacity tests, and they were found to possess a high activity in those tests (Willfoer et al., 2003) . Four lignans, including (+)-9-acetoxyisolariciresinol, lariciresinol, 9-acetoxylariciresinol, and isolariciresinol, isolated from Ephedra viridis exhibited moderate antioxidant activity without any cytotoxicity (Pullela et al., 2005) . Considering the structure-activity relationship, Yamauchi et al. (2007) stated that the benzylic structure without oxygen in the lignan structure, such as in (+)-secoisolariciresinol and 3,4-bis(4-hydroxy-3-methoxybenzyl)tetrahydrofuran, played a major role in the occurrence of the highest antioxidant activity. Therefore, high antioxidant activity of compounds 1 and 2 may be due to this reason. In another study, four lignans [(+)-taxiresinol, (+)-isotaxiresinol, (+)-isolariciresinol, and (-)-secoisolariciresinol] isolated from Taxus cuspidata were tested in DPPH radical scavenging and linethol oxidation (Veselova et al., 2007) . Among them, (+)-isotaxiresinol was the most active against DPPH radicals, and showed a comparable effect to that of α-tocopherol. (+)-Taxiresinol and (+)-isolariciresinol were found to have a moderate scavenging effect in this study as compared to the reference α-tocopherol. In our study, we found these two lignans to be highly active in both antioxidant tests, whose references were different from α-tocopherol. The authors stated that high antioxidant activity of these lignans is associated with the molecular structure containing two ortho hydroxy groups in the aromatic nucleus and having additional aliphatic hydroxy groups.
To the best of our knowledge, we herein report the AChE, BChE, and LOX inhibitory activities as well as the antioxidant capacity by the abovementioned methods of the lignans 1 -5 for the fi rst time.
